Jeremy Ewan Turnbull is a Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, where he leads research in the Glycomics Program. His work focuses on the structure and function of glycosaminoglycans, particularly heparan sulfate, and their roles in various biological processes including immune response and viral infection. Professor Turnbull's research spans glycomics, structural biology, and virology with particular emphasis on heparan sulfate-protein interactions. His work investigates how these complex carbohydrates interact with chemokines, growth factors, and viral proteins including SARS-CoV-2. He has made significant contributions to understanding the molecular mechanisms by which glycosaminoglycans influence immune cell recruitment, tissue repair, and viral pathogenesis. His interdisciplinary approach combines biochemical, structural, and virological techniques to elucidate fundamental biological processes with therapeutic implications. Analysis of Professor Turnbull's recent publications (2020-2023) reveals a strong focus on the intersection of glycobiology and virology, particularly regarding SARS-CoV-2. His research has demonstrated how heparan sulfate serves as an attachment point for the virus and how compounds like heparin and synthetic mimetics can block infection. His work spans structural analysis of carbohydrate-protein interactions, antiviral drug development, and fundamental glycobiology, with publications appearing in high-impact journals including Cell Reports , ACS Central Science , and Science Advances . Professor Turnbull maintains an active research program with substantial collaborative networks, as evidenced by his extensive co-authorship across multiple institutions. His work has attracted significant attention in the scientific community, with numerous citations and media coverage across multiple news outlets and social media platforms. The practical implications of his research for developing antiviral therapeutics are reflected in patent references and real-world applications. Based at the University of Copenhagen's facilities at Blegdamsvej 3 in Copenhagen, Professor Turnbull leads a research group within the Glycomics Program that utilizes advanced biochemical and structural techniques. His laboratory appears well-integrated into the international scientific community, with collaborations spanning multiple countries and disciplines, contributing to both fundamental understanding of glycosaminoglycan biology and potential clinical applications.
